Effects of aerobic exercise with blood flow restriction on COPD patients
Exploring the Effects of Aerobic Exercise Combined with Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
This study is testing if adding blood flow restriction to aerobic exercise can help people with COPD breathe better and exercise more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 30 Years to 85 Years |
| Sex | All |
| Sponsor | National Cheng Kung University Academic / other |
| Locations | 1 site (Tainan, Taiwan) |
| Trial ID | NCT06756646 on ClinicalTrials.gov |
What this trial studies
This study investigates how combining aerobic exercise with blood flow restriction training can improve cardiopulmonary function and exercise capacity in patients with Chronic Obstructive Pulmonary Disease (COPD). It addresses the complications associated with COPD, such as cardiovascular disorders and muscle atrophy, which often lead to decreased physical activity. By incorporating blood flow restriction training into a structured exercise program, the research aims to enhance exercise tolerance and overall quality of life for these patients. The findings could provide insights into a novel rehabilitation strategy for managing COPD.
Who should consider this trial
Good fit: Ideal candidates include individuals with stable COPD classified as levels 2-4 who have not participated in rehabilitation programs recently.
Not a fit: Patients with severe cardiovascular disease, recent hospitalizations, or those dependent on oxygen supply may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve exercise capacity and quality of life for patients with COPD.
How similar studies have performed: While blood flow restriction training is a relatively novel approach, preliminary studies have shown promising results in improving muscle strength and exercise capacity in various populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. COPD classified as levels 2-4. 2. Stable condition without worsening in the past three months. 3. No participation in any rehabilitation program within the past six months. 4. Ability to understand and follow verbal commands and cooperate with an exercise training program. Exclusion Criteria: 1. Unconscious or unable to cooperate with the evaluator. 2. Hospitalization due to acute illness within the past three months. 3. Severe joint diseases or history of lower limb surgery. 4. Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months). 5. Dependence on oxygen supply.
Where this trial is running
Tainan, Taiwan
- National Cheng Kung University Hostipal — Tainan, Taiwan, Taiwan (Recruiting)
Study contacts
- Principal investigator: Kun-Ling Tsai, Ph.D. — Department of Physical Therapy, National Cheng Kung University
- Study coordinator: Kun-Ling Tsai, Ph.D.
- Email: kunlingtsai@mail.ncku.edu.tw
- Phone: 886-6-2353535
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.